HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Anesthesia for thoracic surgery in a female patient with Ullrich congenital muscular dystrophy].

Abstract
Ullrich congenital muscular dystrophy (UCMD) is a rare disease caused by mutations in the COL6A1, COL6A2 or COL6A3 genes leading to deficiency of collagen VI in extracellular matrices (ECM). Patients present with generalized muscle weakness, predominantly in the trunk and proximal limbs, hyperlaxity of distal joints, spinal rigidity, scoliosis and various proximal joint contractures, loss of ambulation by 9-11 years of age and progressive respiratory dysfunction. About 50% of the patients require noninvasive ventilation (NIV) by the age of 11-12 years. We report about a female patient (age 21 years) with severe UCMD. After decompression of spontaneous pneumothorax, a major subpleural hematoma of the left lower lobe emerged necessitating video-assisted thoracoscopic surgery (VATS). Anesthesiological aspects, including underlying disease, comorbidities, airway management for one-lung ventilation and choice of anesthetics for patients with muscular dystrophy are discussed. The clinical course during anesthesia, surgery and postoperatively was uneventful and the patient was discharged 7 days after VATS.
AuthorsThomas Hachenberg, Thorsten Walles, Eva Lücke, Thomas Schilling
JournalDie Anaesthesiologie (Anaesthesiologie) Vol. 71 Issue 10 Pg. 784-788 (10 2022) ISSN: 2731-6866 [Electronic] Germany
Vernacular TitleAnästhesie bei einer thoraxchirurgischen Patientin mit kongenitaler Muskeldystrophie Typ Ullrich.
PMID35925158 (Publication Type: Journal Article)
Copyright© 2022. The Author(s).
Chemical References
  • Collagen Type VI
Topics
  • Adult
  • Anesthesia
  • Child
  • Collagen Type VI
  • Female
  • Humans
  • Muscular Dystrophies (genetics)
  • Sclerosis
  • Thoracic Surgery
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: